Is RenovoRx Inc (RNXT) Stock at the Top of the Biotechnology Industry?

A rating of 60 puts RenovoRx Inc (RNXT) near the middle of the Biotechnology industry according to InvestorsObserver. RenovoRx Inc's score of 60 means it scores higher than 60% of stocks in the industry. RenovoRx Inc also received an overall rating of 53, putting it above 53% of all stocks. Biotechnology is ranked 31 out of the 148 industries.

RNXT has an Overall Score of 53. Find out what this means to you and get the rest of the rankings on RNXT!

See Full RNXT Report

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With RenovoRx Inc Stock Today?

RenovoRx Inc (RNXT) stock has gained 8.37% while the S&P 500 has fallen -0.27% as of 10:16 AM on Wednesday, Jun 28. RNXT is up $0.18 from the previous closing price of $2.15 on volume of 37,970 shares. Over the past year the S&P 500 has gained 14.26% while RNXT is up 19.49%. RNXT lost -$1.12 per share the over the last 12 months. Click Here to get the full Stock Report for RenovoRx Inc stock.